Posts from ‘April, 2010’

BOSTON–(HSMN NewsFeed)–SV Life Sciences ("SVLS") today announced the appointment of Paul Wallace, an executive with over 18 years of experience in health care services operations and private equity investing, as a Venture Senior partner. Mr. Wallace w…
Biopharmaceuticals, Devices, Venture Capital, Personnel
SV Life Sciences

PITTSBURGH, April 22 (HSMN NewsFeed) — Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study o…
Devices, Orthopaedic, Neurosurgery, FDA
Flexuspine, Functional Spinal Unit, Total Spine Arthroplasty

New Technology 100% Radiation-Free ALBUQUERQUE, N.M.–(HSMN NewsFeed)–Manhattan Scientifics, Inc. (OTCBB: MHTX ) announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast …
Devices, Oncology
Manhattan Scientifics, breast cancer, mammography

Company Also Completes Financing with Big Pharmaceutical Device, Pharmaceutical and Semiconductor Companies as Investors REDWOOD CITY, Calif.–(HSMN NewsFeed)–Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that it has received…
Devices, Monitoring, FDA
Proteus Biomedical, Raisin Personal Monitor

MONMOUTH JUNCTION, N.J., April 21–(HSMN NewsFeed)–TYRX, Inc. announced today the appointment of former Medtronic-Kyphon executive Randy Mansfield as Vice President of Product management effective immediately. Mr. Mansfield brings over Twenty years of sales, market…
Devices, Personnel
TYRX, AIGISRx, Anti-Bacterial Envelope

Supports Promising Phase 2b Clinical Program for Obatoclax in Miniature Cell Lung Cancer; Data Expected in 2Q 2010 MALVERN, Pa. & MONTRÉAL–(HSMN NewsFeed)–Gemin X Pharmaceuticals, a medical stage biopharmaceutical company developing novel, targ…
Biopharmaceuticals, Oncology, Venture Capital
Gemin X Pharmaceuticals, obatoclax

LDR prepares PMA submission for FDA review of the Mobi-C® cervical artificial disc AUSTIN, Texas–(HSMN NewsFeed)–LDR, a privately held company with innovative spinal implants for non-fusion and fusion applications, announced completion of the 24-m…
Devices, Neurosurgery, Orthopaedic
LDR Spine, Mobi-C, cervical artificial disc, spine surgery

Company’s patented endothelial progenitor cell (EPC) capture technology now available on thinner, flexible stent HONG KONG, April 20 (HSMN NewsFeed) — OrbusNeich announced that following CE Mark (Conformite Europeenne) approval, its Genous Bio-engin…
Devices, Interventional Cardiology, Regulatory
OrbusNeich, Genous Bio-engineered, Genous stent

GammaLoc(R) Helps Locate Breast Lesions Quickly and Accurately for Biopsy MONTGOMERY, Ala., April 20 (HSMN NewsFeed) — The Montgomery Breast Center of Montgomery, Ala., is the first center in the country to install and use the GammaLoc® lesion-lo…
Devices, Radiology, Oncology
Dilon Diagnostics, GammaLoc, Breast-Specific Gamma Imaging, gamma camera

SALT LAKE CITY, April 19, 2010 –(HSMN NewsFeed) — Myriad Pharmaceuticals, Inc. (Nasdaq:MYRX ) today announced the termination, effective as of Friday, April 16, 2010, of its merger agreement with Javelin Pharmaceuticals (NYSE Amex:JAV). In accordance …
Biopharmaceuticals, Mergers & Acquisitions
Myriad Pharmaceuticals, Javelin Pharmaceuticals